Firm Client, Cypris Therapeutics, a partner of Ichor Life Sciences has secured over $500,000 in pre-seed funding. This chemistry-focused pharmaceutical start-up company has developed lifesaving therapies which may help treat certain types of cancers and other deadly diseases. Their cutting-edge technology will no doubt have a significant impact on the lives of patients.
About Us:
Newman & Lickstein, LLP is recognized as a leading law firm serving the life sciences and biotechnology industries. Our cross-disciplinary legal team partners with clients throughout the pivotal moments of their corporate lifecycle to achieve their most critical business and legal goals. Our attorneys advise clients on the formation, financing, intellectual property, research, and development through the clinical stage.
